Home / Pharma Healthcare / Global and China Drugs for Treatment of Non-small-Cell Lung Cancer Research Report to 2020

Global and China Drugs for Treatment of Non-small-Cell Lung Cancer Research Report to 2020

  • Id : RNR-2155
  • Category : Pharma Healthcare
  • Publish Date : 17/Jun
  • Pages : 136
  • Format : PDF
License Type

Description
The global Drugs for Treatment of Non-small-Cell Lung Cancer market was valued at USD 74.8 Billion in 2015, and is projected to reach USD 109 Billion by 2021, at a CAGR of 7.82% between 2016 and 2021. The market is projected witness significant growth in the coming years, owing to the aging population increase, increased incidence and development of new drugs

This report studies Drugs for Treatment of Non-small-Cell Lung Cancer in Global and China market, focuses on price, sales, revenue of each type in global China. This report also focuses on the sales (consumption), production, import and export of Drugs for Treatment of Non-small-Cell Lung Cancer in US, Japan, Western Europe, Japan and China, forecast to 2020, from 2015.

Split by product types, with sales, revenue, market share and price of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers, in 2015 and 2016, covering 
Avastin
Afatinib
Pemetrexed
Erlotinib
Paclitaxel
Compound cantharidin capsule
Gefitinib
Apa imatinib
Crizotinib
Docetaxel
S-1
Doxorubicin
Gemcitabine
Javanica oil soft capsule
Tagrisso

Split by manufacturers, this report focuses on the sales, price of each type, average price of Treatment of Non-small-Cell Lung Cancer, revenue and market share, for each manufacturer in 2015 and 2016. Top players, covering 
Roche 
Boehringer Ingelheim GmbH 
Eli lily 
Celgene 
AstraZeneca 
Pfizer 
Sanofi 
Taiho 
Johnson 
Qilu Pharmaceutical
??

Split by regions, this report focuses on the sales (consumption), production, import and export of Drugs for Treatment of Non-small-Cell Lung Cancer in US, Western Europe, Japan and China, from 2011 to 2020 (forecast), covering 
US
Western Europe
Japan
China

With 210pages, 178 charts and eight chapters, to display the market present situation and future, clearly and deeply.